Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved crawled date : 2021 - 09 - 28 save search
Navient, Maximus Announce Proposal to Transfer Federal Student Loan Servicing Contract, Pending Government Approval
Published: 2021-09-28 (Crawled : 21:00) - globenewswire.com
MMS 4 | $81.44 1.75% 0.0% 280K
|
Commercial Services
|
| O: 0.37%
H: 1.4%
C: 0.98%
AVNT | $42.52 0.38% -0.12% 620K
|
Process Industries
|
| O: -0.13%
H: 0.9%
C: 0.57%
NAVI | $16.19 -0.43% -0.43% 1.1M
|
Finance
|
| O: 0.07%
H: 0.51%
C: -13.97%
contract approval
Grupo Aeroportuario Del Pacifico Pays Capital Stock Reduction Approved at the Extraordinary Shareholders’ Meeting
Published: 2021-09-28 (Crawled : 21:00) - globenewswire.com
PAC | $156.15 0.16% 0.0% 42K
|
Transportation
|
| O: 0.63%
H: 0.0%
C: -1.1%
approval
Navigator Gas awarded approval in principle for ammonia fuelled gas carrier by classification society DNV
Published: 2021-09-28 (Crawled : 15:00) - navigatorgas.com
NVGS | $14.97 0.94% 0.0% 170K
|
Transportation
|
| O: 0.81%
H: 2.86%
C: 0.8%
BW | News | $0.9279 -4.18% 0.0% 1.1M
|
Electronic Technology
|
| O: 0.15%
H: 5.86%
C: -2.0%
approval
Medtronic Receives CE Mark Approval for Radial Artery Access Portfolio
Published: 2021-09-28 (Crawled : 06:00) - prnewswire.com
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: -0.73%
H: 0.1%
C: -1.42%
ce mark approval
Eisai Initiates Rolling Submission To The U.S. FDA For Biologics License Application Of Lecanemab (BAN2401) For Early Alzheimer's Disease Under The Accelerated Approval Pathway
Published: 2021-09-28 (Crawled : 06:00) - biospace.com/
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 1.47%
H: 0.25%
C: -2.1%
disease alzheimer fda license approval submission alzheimer’s alzheimer's disease alzheimer's lecanemab
Eisai Initiates Rolling Submission To The U.S. FDA For Biologics License Application Of Lecanemab (BAN2401) For Early Alzheimer's Disease Under The Accelerated Approval Pathway
Published: 2021-09-27 (Crawled : 00:00) - prnewswire.com
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 1.47%
H: 0.25%
C: -2.1%
disease alzheimer fda license approval submission alzheimer’s alzheimer's disease alzheimer's lecanemab
ChemoCentryx Announces Approval in Japan of TAVNEOS™ (Avacopan) for the Treatment of ANCA-Associated Vasculitis
Published: 2021-09-27 (Crawled : 00:00) - globenewswire.com
CCXI | $51.99 -0.04%
|
Health Technology
|
| O: 4.18%
H: 3.8%
C: 1.32%
treatment approval avacopan
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.